Natural Killer Cells Therapeutics Market Report

China Natural Killer Cells Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Oct 05, 2023
  • PAGES：162
  • REPORT CODE：GMM1829532
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Natural Killer Cells Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Affimed

    • Fortress Biotech

    • Ziopharm Oncology

    • Celgene Corporation

    • Nkarta Therapeutics

    • Innate Pharma

    • Nantkwest

    • Fate Therapeutics

    • Glycostem Therapeutics

    By Type:

    • NK Cell Directed Antibodies

    • NK Cell Therapies

    By Application:

    • Others

    • Hospitals

    • Research Centers & Institutes

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Natural Killer Cells Therapeutics Market Overview 2018-2029

    • 1.1 China Natural Killer Cells Therapeutics Industry Development Overview

    • 1.2 China Natural Killer Cells Therapeutics Industry Development History

    • 1.3 China Natural Killer Cells Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Natural Killer Cells Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Natural Killer Cells Therapeutics Production Volume, Production Value and Growth Rate of NK Cell Directed Antibodies (2018-2029)

      • 1.4.2 China Natural Killer Cells Therapeutics Production Volume, Production Value and Growth Rate of NK Cell Therapies (2018-2029)

    • 1.5 China Natural Killer Cells Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.3 China Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate of Research Centers & Institutes (2018-2029)

    • 1.6 China Natural Killer Cells Therapeutics Market Analysis by Region

      • 1.6.1 North China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Natural Killer Cells Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Natural Killer Cells Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Natural Killer Cells Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Natural Killer Cells Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Natural Killer Cells Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Natural Killer Cells Therapeutics Industry Development

    Chapter 3 Natural Killer Cells TherapeuticsIndustry Chain Analysis

    • 3.1 Natural Killer Cells Therapeutics Industry Chain

    • 3.2 Natural Killer Cells Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Natural Killer Cells Therapeutics Market

    • 3.3 Natural Killer Cells Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Natural Killer Cells Therapeutics Market

    Chapter 4 China Natural Killer Cells Therapeutics Market, by Type

    • 4.1 China Natural Killer Cells Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Natural Killer Cells Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Natural Killer Cells Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Natural Killer Cells Therapeutics Production Volume and Growth Rate of NK Cell Directed Antibodies

      • 4.5.2 China Natural Killer Cells Therapeutics Production Volume and Growth Rate of NK Cell Therapies

    Chapter 5 China Natural Killer Cells Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Natural Killer Cells Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Natural Killer Cells Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Natural Killer Cells Therapeutics Market Size and Growth Rate of Others

      • 5.5.2 China Natural Killer Cells Therapeutics Market Size and Growth Rate of Hospitals

      • 5.5.3 China Natural Killer Cells Therapeutics Market Size and Growth Rate of Research Centers & Institutes

    Chapter 6 China Natural Killer Cells Therapeutics Market, by Region

    • 6.1 China Natural Killer Cells Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Natural Killer Cells Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Natural Killer Cells Therapeutics Market Analysis

    • 7.1 North China Natural Killer Cells Therapeutics Market, by Type

    • 7.2 North China Natural Killer Cells Therapeutics Market, by Application

    Chapter 8 Central China Natural Killer Cells Therapeutics Market Analysis

    • 8.1 Central China Natural Killer Cells Therapeutics Market, by Type

    • 8.2 Central China Natural Killer Cells Therapeutics Market, by Application

    Chapter 9 South China Natural Killer Cells Therapeutics Market Analysis

    • 9.1 South China Natural Killer Cells Therapeutics Market, by Type

    • 9.2 South China Natural Killer Cells Therapeutics Market, by Application

    Chapter 10 East China Natural Killer Cells Therapeutics Market Analysis

    • 10.1 East China Natural Killer Cells Therapeutics Market, by Type

    • 10.2 East China Natural Killer Cells Therapeutics Market, by Application

    Chapter 11 Northeast China Natural Killer Cells Therapeutics Market Analysis

    • 11.1 Northeast China Natural Killer Cells Therapeutics Market, by Type

    • 11.2 Northeast China Natural Killer Cells Therapeutics Market, by Application

    Chapter 12 Southwest China Natural Killer Cells Therapeutics Market Analysis

    • 12.1 Southwest China Natural Killer Cells Therapeutics Market, by Type

    • 12.2 Southwest China Natural Killer Cells Therapeutics Market, by Application

    Chapter 13 Northwest China Natural Killer Cells Therapeutics Market Analysis

    • 13.1 Northwest China Natural Killer Cells Therapeutics Market, by Type

    • 13.2 Northwest China Natural Killer Cells Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Affimed

        • 14.1.1 Affimed Company Profile

        • 14.1.2 Affimed Natural Killer Cells Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Fortress Biotech

        • 14.2.1 Fortress Biotech Company Profile

        • 14.2.2 Fortress Biotech Natural Killer Cells Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Ziopharm Oncology

        • 14.3.1 Ziopharm Oncology Company Profile

        • 14.3.2 Ziopharm Oncology Natural Killer Cells Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Celgene Corporation

        • 14.4.1 Celgene Corporation Company Profile

        • 14.4.2 Celgene Corporation Natural Killer Cells Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Nkarta Therapeutics

        • 14.5.1 Nkarta Therapeutics Company Profile

        • 14.5.2 Nkarta Therapeutics Natural Killer Cells Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Innate Pharma

        • 14.6.1 Innate Pharma Company Profile

        • 14.6.2 Innate Pharma Natural Killer Cells Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Nantkwest

        • 14.7.1 Nantkwest Company Profile

        • 14.7.2 Nantkwest Natural Killer Cells Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Fate Therapeutics

        • 14.8.1 Fate Therapeutics Company Profile

        • 14.8.2 Fate Therapeutics Natural Killer Cells Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Glycostem Therapeutics

        • 14.9.1 Glycostem Therapeutics Company Profile

        • 14.9.2 Glycostem Therapeutics Natural Killer Cells Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Natural Killer Cells Therapeutics Industry Research Conclusions

    • 15.2 Natural Killer Cells Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Natural Killer Cells Therapeutics Industry Market Size (2018-2029)

    • Figure China Natural Killer Cells Therapeutics Production Volume, Production Value and Growth Rate of NK Cell Directed Antibodies (2018-2029)

    • Figure China Natural Killer Cells Therapeutics Production Volume, Production Value and Growth Rate of NK Cell Therapies (2018-2029)

    • Figure China Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate of Research Centers & Institutes (2018-2029)

    • Figure North China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Natural Killer Cells Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Natural Killer Cells Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Natural Killer Cells Therapeutics Market Share by Type in 2018

    • Figure China Natural Killer Cells Therapeutics Market Share by Type in 2023

    • Figure China Natural Killer Cells Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Natural Killer Cells Therapeutics Production Volume and Growth Rate of NK Cell Directed Antibodies (2018-2023)

    • Figure China Natural Killer Cells Therapeutics Production Volume and Growth Rate of NK Cell Therapies (2018-2023)

    • Figure China Natural Killer Cells Therapeutics Market Share by Application in 2018

    • Figure China Natural Killer Cells Therapeutics Market Share by Application in 2023

    • Figure China Natural Killer Cells Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Natural Killer Cells Therapeutics Market Size and Growth Rate of Others (2018-2023)

    • Figure China Natural Killer Cells Therapeutics Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Natural Killer Cells Therapeutics Market Size and Growth Rate of Research Centers & Institutes (2018-2023)

    • Table China Natural Killer Cells Therapeutics Production Volume by Region (2018-2023)

    • Table China Natural Killer Cells Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Natural Killer Cells Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Natural Killer Cells Therapeutics Production Value by Region (2018-2023)

    • Table China Natural Killer Cells Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Natural Killer Cells Therapeutics Production Value Share by Region (2018-2023)

    • Table China Natural Killer Cells Therapeutics Sales Volume by Region (2018-2023)

    • Table China Natural Killer Cells Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Natural Killer Cells Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Natural Killer Cells Therapeutics Sales Value by Region (2018-2023)

    • Table China Natural Killer Cells Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Natural Killer Cells Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Natural Killer Cells Therapeutics Production Volume by Type (2018-2023)

    • Table North China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Natural Killer Cells Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Natural Killer Cells Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Natural Killer Cells Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Natural Killer Cells Therapeutics Production Volume by Type (2018-2023)

    • Table South China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Natural Killer Cells Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Natural Killer Cells Therapeutics Production Volume by Type (2018-2023)

    • Table East China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Natural Killer Cells Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Natural Killer Cells Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Natural Killer Cells Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Natural Killer Cells Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Natural Killer Cells Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Natural Killer Cells Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Natural Killer Cells Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Natural Killer Cells Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Natural Killer Cells Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Affimed Company Profile

    • Table Affimed Natural Killer Cells Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Fortress Biotech Company Profile

    • Table Fortress Biotech Natural Killer Cells Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Ziopharm Oncology Company Profile

    • Table Ziopharm Oncology Natural Killer Cells Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Celgene Corporation Company Profile

    • Table Celgene Corporation Natural Killer Cells Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Nkarta Therapeutics Company Profile

    • Table Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Innate Pharma Company Profile

    • Table Innate Pharma Natural Killer Cells Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Nantkwest Company Profile

    • Table Nantkwest Natural Killer Cells Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Fate Therapeutics Company Profile

    • Table Fate Therapeutics Natural Killer Cells Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Glycostem Therapeutics Company Profile

    • Table Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US